136 related articles for article (PubMed ID: 12382203)
1. The copper-iron connection: hereditary aceruloplasminemia.
Nittis T; Gitlin JD
Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
[TBL] [Abstract][Full Text] [Related]
2. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
Kenawi M; Rouger E; Island ML; Leroyer P; Robin F; Rémy S; Tesson L; Anegon I; Nay K; Derbré F; Brissot P; Ropert M; Cavey T; Loréal O
FASEB J; 2019 Dec; 33(12):13492-13502. PubMed ID: 31560858
[TBL] [Abstract][Full Text] [Related]
3. [Aceruloplasminemia, a rare condition not to be overlooked].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
[TBL] [Abstract][Full Text] [Related]
4. Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant.
Gok V; Ozcan A; Ozer S; Karaman F; Aykutlu E; Yilmaz E; Karakukcu M; Bisgin A; Unal E
Pediatr Hematol Oncol; 2023; 40(7):673-681. PubMed ID: 36308763
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
6. Aceruloplasminemia.
Miyajima H
Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing aceruloplasminemia: navigating through red herrings.
Kharel Z; Kharel H; Phatak PD
Ann Hematol; 2024 Jun; 103(6):2173-2176. PubMed ID: 38637332
[TBL] [Abstract][Full Text] [Related]
9. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
[TBL] [Abstract][Full Text] [Related]
10. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of heterozygosis for aceruloplasminemia.
Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
[TBL] [Abstract][Full Text] [Related]
12. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.
Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A
Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721
[TBL] [Abstract][Full Text] [Related]
13. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.
Ondrejkovičová M; Dražilová S; Drakulová M; Siles JL; Zemjarová Mezenská R; Jungová P; Fabián M; Rychlý B; Žigrai M
BMC Gastroenterol; 2020 Apr; 20(1):95. PubMed ID: 32264837
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
[TBL] [Abstract][Full Text] [Related]
15. Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.
Watanabe M; Ohyama K; Suzuki M; Nosaki Y; Hara T; Iwai K; Kono S; Miyajima H; Mokuno K
Intern Med; 2018 Sep; 57(18):2713-2718. PubMed ID: 29709961
[TBL] [Abstract][Full Text] [Related]
16. Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
Wang B; Wang XP
Curr Neuropharmacol; 2019; 17(6):539-549. PubMed ID: 29737252
[TBL] [Abstract][Full Text] [Related]
17. Aceruloplasminemia: Waiting for an Efficient Therapy.
Piperno A; Alessio M
Front Neurosci; 2018; 12():903. PubMed ID: 30568573
[TBL] [Abstract][Full Text] [Related]
18. Novel ceruloplasmin gene mutation causing aceruloplasminemia with diabetes in a Chinese woman: a case report.
Xiao Y; Zhu C; Jiang F; Gao Q; Lu H; Wang C; Wei L
Ann Palliat Med; 2022 Jul; 11(7):2516-2522. PubMed ID: 34670377
[TBL] [Abstract][Full Text] [Related]
19. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.
Poli L; Alberici A; Buzzi P; Marchina E; Lanari A; Arosio C; Ciccone A; Semeraro F; Gasparotti R; Padovani A; Borroni B
Neurol Sci; 2017 Feb; 38(2):357-360. PubMed ID: 27817091
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
